Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/03/2005EP1558235A2 Methods of treatment during vascular procedures
08/03/2005EP1558234A1 Painless injectable compositions containing salt of 2-arylpropionic acids
08/03/2005EP1558232A2 Treating obesity with selective androgen receptor modulators
08/03/2005EP1558231A2 Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
08/03/2005EP1558229A1 Combination of a cdk inhibitor and mitoxantrone
08/03/2005EP1558228A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
08/03/2005EP1558227A1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods
08/03/2005EP1558226A2 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
08/03/2005EP1558225A1 Adhesive composition for dermal patch and production process thereof
08/03/2005EP1558222A2 Pharmaceutical compositions containing venlafaxine
08/03/2005EP1558221A1 Dosage form that is safeguarded from abuse
08/03/2005EP1558219A1 Pharmaceutical formulation of olanzapine
08/03/2005EP1558218A1 Gabapentin tablets and methods for their preparation
08/03/2005EP1558217A1 Wet granulation process
08/03/2005EP1558216A2 Cross-linked polymer matrices, and methods of making and using same
08/03/2005EP1558214A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same
08/03/2005EP1558213A2 Mucoadhesive tetracycline formulations
08/03/2005EP1558210A2 Cartilage enhancing food supplements with sucralose and methods of preparing the same
08/03/2005EP1558207A1 Topical anhydrous delivery system for antioxidants
08/03/2005EP1558202A1 Water soluble monomers and polymers for protecting subtrates from ultraviolet light
08/03/2005EP1558199A2 Therapeutic combination of carnitine and antioxidant polyphenols
08/03/2005EP1558083A2 Compounds, compositions, and methods
08/03/2005EP1558081A2 Method of treating functional bowel disorders
08/03/2005EP1558080A2 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
08/03/2005EP1450823A4 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
08/03/2005EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/03/2005EP1429750A4 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/03/2005EP1418937A4 Enhancing organ maturity in neonates and predicting their duration of intensive care
08/03/2005EP1399458B1 An arylation method for the functionalization of o-allyl erythromycin derivatives
08/03/2005EP1399446B1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1284737B1 Water soluble prodrugs of azole compounds
08/03/2005EP1283708B1 Use of biguanide derivatives for making a medicine having a wound healing effect
08/03/2005EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1227806B1 Pharmaceutical formulation containing tolterodine and its use
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium
08/03/2005EP1194169B1 Stabilized vitamin c formulations
08/03/2005EP1175433B1 Androgen glycosides and androgenic activity thereof
08/03/2005EP1141111B1 Gel compositions
08/03/2005EP1140106B1 Treatment of diseases involving cyst formation
08/03/2005EP1071671B1 Triazolones with a neuroprotective action
08/03/2005EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
08/03/2005EP0988108B1 superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0844869B1 Ulmwh (ultra-low-molecular weight heparin) for treating asthma
08/03/2005EP0832651B1 Use of fructooligosaccharides (FOS) for lowering blood lipid peroxide level
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1650033A Genomic screen for epigenetically silenced genes associated with cancer
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650010A Method for inhibiting the expression of a target gene and medicine for treating tumor disease
08/03/2005CN1650001A Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinop
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649891A Improved synthesis of cyproterone acetate
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649884A Novel azacyclic ethynyl derivatives
08/03/2005CN1649883A Bicyclic 6-alkylidene-penems as lactamases inhibitors
08/03/2005CN1649882A Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors
08/03/2005CN1649879A Non-steroidal progesterone receptor modulators
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649875A 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649874A Antiparasitic artemisinin derivatives (endoperoxides)
08/03/2005CN1649873A Camptothecin-taxoid conjugates as antimitotic and antitumor agents
08/03/2005CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives
08/03/2005CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649868A Process for preparing acid salts of gemifloxacin
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649866A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649862A Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649856A 4-(diarylmethyl)-1-piperazinyl derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649847A Method for producing optically active sulfoxide derivative
08/03/2005CN1649846A Compounds of the family of 3-alkyl-(4, 5-diphenyl-imidazol-1-yl) and their use as soothing agents
08/03/2005CN1649844A Isoquinoline derivatives
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649840A Non-peptidic BRS-3 agonists
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
08/03/2005CN1649826A 5-amino-1-pentene-3-ol substituted derivatives
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649627A Methods and conpositions for treating, preventing or delaying onset of a neoplasm
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
1 ... 4594 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 4606 4607 4608 4609 4610 4611 4612 4613 4614 ... 7860